Clinical cancer chemoprevention: From the hepatitis B virus (HBV) vaccine to the human papillomavirus (HPV) vaccine
Approximately 2 million new cancer cases are attributed to infectious agents each year worldwide. Vaccines for the hepatitis B virus (HBV), a risk factor of hepatocellular cancer, and human papillomavirus (HPV), a risk factor of cervical cancer, are considered major successes in clinical chemopreven...
| Váldodahkki: | Horng-Jyh Tsai |
|---|---|
| Materiálatiipa: | Artihkal |
| Giella: | English |
| Almmustuhtton: |
Elsevier
2015-04-01
|
| Ráidu: | Taiwanese Journal of Obstetrics & Gynecology |
| Fáttát: | |
| Liŋkkat: | http://www.sciencedirect.com/science/article/pii/S1028455915000212 |
Geahča maid
-
Barriers and Facilitators of Romanian HPV (Human Papillomavirus) Vaccination
Dahkki: Loredana Sabina Cornelia Manolescu, et al.
Almmustuhtton: (2022-10-01) -
Association of provider HPV vaccination training with provider assessment of HPV vaccination status and recommendation of HPV vaccination
Dahkki: Ikponmwosa Osaghae, et al.
Almmustuhtton: (2022-11-01) -
Descriptive epidemiology of age at HPV vaccination: Analysis using the 2020 NIS-Teen
Dahkki: Robert A. Bednarczyk, et al.
Almmustuhtton: (2023-01-01) -
Parents’ Knowledge and Attitude towards HPV and HPV Vaccination in Poland
Dahkki: Katarzyna Smolarczyk, et al.
Almmustuhtton: (2022-02-01) -
Exploration of the effect of human papillomavirus (HPV) vaccination in a cohort of pregnant women in Montreal, 2010–2016
Dahkki: El Hadji Malick Sarr, et al.
Almmustuhtton: (2019-08-01)